Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 7/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.35 |
| ▸ | OGA | O60502 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25461965 | 0.90 | TGFBR1 (0.41) | TGFBR1CYP3A4GPR3ALDH1A1RAB9A | |
| SCHEMBL25462004 | 0.86 | NPC1 (0.42) | GPR3ALDH1A1RAB9ANPC1KDM4E | |
| SCHEMBL25461712 | 0.85 | RAB9A (0.43) | TGFBR1CYP3A4GPR3ALDH1A1RAB9A | |
| SCHEMBL25462095 | 0.84 | MAPT (0.41) | CYP3A4GPR3ALDH1A1RAB9ANPC1 | |
| SCHEMBL25462016 | 0.84 | NPC1 (0.54) | CYP3A4GPR3ALDH1A1RAB9ANPC1 | |
| SCHEMBL25462013 | 0.84 | NPC1 (0.40) | CYP3A4GPR3ALDH1A1RAB9ANPC1 | |
| SCHEMBL26835845 | 0.83 | PIK3CD (0.43) | TGFBR1CYP3A4GPR3ALDH1A1RAB9A | |
| SCHEMBL25461998 | 0.82 | GPR3 (0.37) | CYP3A4GPR3ALDH1A1RAB9ANPC1 | |
| SCHEMBL25462001 | 0.81 | GPR3 (0.36) | CYP3A4GPR3ALDH1A1RAB9ANPC1 | |
| SCHEMBL25462000 | 0.81 | MAP4K4 (0.42) | CYP3A4GPR3ALDH1A1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151020-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151020-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | OCIAD1, OCIAD2, EHD1 | TGFBR1 1969/4885CYP3A4 949/4885GPR3 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.